 <h1>Lysodren Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>mitotane</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about mitotane. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Lysodren.</p><h2>In Summary</h2><p><b>Common side effects of Lysodren include:</b> lethargy and vertigo.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to mitotane: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>In patients taking mitotane, adrenal crisis occurs in the setting of shock or severe trauma and response to shock is impaired. Administer hydrocortisone, monitor for escalating signs of shock and discontinue mitotane until recovery.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, mitotane (the active ingredient contained in Lysodren) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking mitotane:</p><p>
<i>More common</i>
</p><ul>
<li>Darkening of the skin</li>
<li>diarrhea</li>
<li>dizziness or lightheadedness</li>
<li>drowsiness</li>
<li>loss of appetite</li>
<li>mental depression</li>
<li>nausea or vomiting</li>
<li>skin rash</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blood in the urine</li>
<li>blurred vision</li>
<li>double vision</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloating</li>
<li>chills</li>
<li>cloudy urine</li>
<li>cold sweats</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position</li>
<li>feeling of warmth</li>
<li>fever</li>
<li>frequent urination</li>
<li>headache</li>
<li>pelvic cramping, discomfort, pain, or heaviness</li>
<li>nervousness</li>
<li>painful urination</li>
<li>pounding in the ears</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>slow or fast heartbeat</li>
<li>vaginal bleeding</li>
<li>vision changes</li>
<li>white area over the eye</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of mitotane may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Feeling of constant movement of self or surroundings</li>
<li>indigestion</li>
<li>passing of gas</li>
<li>sensation of spinning</li>
<li>sleepiness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Aching muscles</li>
<li>flushing or redness of the skin</li>
<li>muscle twitching</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to mitotane: oral tablet</i></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Adrenal insufficiency, gynecomastia</p>
<p><b>Frequency not reported</b>: Thyroid impairment, lowered protein-bound iodine (PBI)</p>
<p><b>Postmarketing reports</b>: Growth retardation, hypothyroidism<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): CNS effects (up to 40%; primarily depression as manifested by lethargy and somnolence 25%, and dizziness or vertigo 15%), ataxia, paresthesia, sleepiness</p>
<p><b>Common</b> (1% to 10%): Mental impairment, polyneuropathy, movement disorder, headache</p>
<p><b>Frequency not reported</b>: Balance disorders, dysgeusia, memory defects, central vestibular syndrome, Parkinson's syndrome, encephalopathy</p>
<p><b>Postmarketing reports</b>: Neuropsychological disturbance, dysarthria<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Prolonged bleeding time (up to 90%), leukopenia/neutropenia (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Anemia, thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Elevated liver enzymes (gamma-GT, aminotransferase, alkaline phosphatase) </p>
<p><b>Common</b> (1% to 10%): Autoimmune hepatitis</p>
<p><b>Frequency not reported</b>: Liver damage </p>
<p><b>Postmarketing reports</b>: Hepatitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): GI disturbances (up to 80%; anorexia, nausea, vomiting, diarrhea), mucositis, epigastric discomfort</p>
<p><b>Frequency not reported</b>: Salivary hypersecretion, dyspepsia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Hypertension, orthostatic hypotension, flushing<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Skin toxicity/skin rash (up to 25%)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hematuria, hemorrhagic cystitis, albuminuria, proteinuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Increased plasma cholesterol/hypercholesterolemia, increased plasma triglycerides/hypertriglyceridemia</p>
<p><b>Postmarketing reports</b>: Decreased blood uric acid/hypouricemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Myasthenia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, diplopia, lens opacity, toxic retinopathy, visual impairment</p>
<p><b>Postmarketing reports</b>: Maculopathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia</p>
<p><b>Frequency not reported</b>: Generalized aching, hyperpyrexia, opportunistic mycosis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Confusion</p>
<p><b>Frequency not reported</b>: Aggressiveness<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Lysodren (mitotane)." Bristol-Myers Squibb, Princeton, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Lysodren (mitotane)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lysodren &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Adrenal Cortical Carcinoma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to mitotane: oral tablet</i></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Adrenal insufficiency, gynecomastia</p><p><b>Frequency not reported</b>: Thyroid impairment, lowered protein-bound iodine (PBI)</p><p><b>Postmarketing reports</b>: Growth retardation, hypothyroidism<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): CNS effects (up to 40%; primarily depression as manifested by lethargy and somnolence 25%, and dizziness or vertigo 15%), ataxia, paresthesia, sleepiness</p><p><b>Common</b> (1% to 10%): Mental impairment, polyneuropathy, movement disorder, headache</p><p><b>Frequency not reported</b>: Balance disorders, dysgeusia, memory defects, central vestibular syndrome, Parkinson's syndrome, encephalopathy</p><p><b>Postmarketing reports</b>: Neuropsychological disturbance, dysarthria<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Prolonged bleeding time (up to 90%), leukopenia/neutropenia (up to 12%)</p><p><b>Common</b> (1% to 10%): Anemia, thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Elevated liver enzymes (gamma-GT, aminotransferase, alkaline phosphatase) </p><p><b>Common</b> (1% to 10%): Autoimmune hepatitis</p><p><b>Frequency not reported</b>: Liver damage </p><p><b>Postmarketing reports</b>: Hepatitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): GI disturbances (up to 80%; anorexia, nausea, vomiting, diarrhea), mucositis, epigastric discomfort</p><p><b>Frequency not reported</b>: Salivary hypersecretion, dyspepsia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Hypertension, orthostatic hypotension, flushing<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Skin toxicity/skin rash (up to 25%)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hematuria, hemorrhagic cystitis, albuminuria, proteinuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Increased plasma cholesterol/hypercholesterolemia, increased plasma triglycerides/hypertriglyceridemia</p><p><b>Postmarketing reports</b>: Decreased blood uric acid/hypouricemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Myasthenia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, diplopia, lens opacity, toxic retinopathy, visual impairment</p><p><b>Postmarketing reports</b>: Maculopathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia</p><p><b>Frequency not reported</b>: Generalized aching, hyperpyrexia, opportunistic mycosis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Confusion</p><p><b>Frequency not reported</b>: Aggressiveness<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Lysodren (mitotane)." Bristol-Myers Squibb, Princeton, NJ. </p><h2>More about Lysodren (mitotane)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lysodren &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Adrenal Cortical Carcinoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>